Imunon, Inc. Stock Issued During Period, Value, Treasury Stock Reissued
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Imunon, Inc. stock issued during period, value, treasury stock reissued for the quarter ending 2012-03-31 was $50.38K, a 267.55% increase year-over-year.
- Imunon, Inc. stock issued during period, value, treasury stock reissued for the quarter ending 2011-12-31 was $15.72K.
- Imunon, Inc. stock issued during period, value, treasury stock reissued for the quarter ending 2011-03-31 was $13.71K.
- Imunon, Inc. stock issued during period, value, treasury stock reissued for fiscal 2016 was $101.49K, a 17.02% increase from fiscal 2015.
- Imunon, Inc. stock issued during period, value, treasury stock reissued for fiscal 2015 was $86.73K, a 34.50% increase from fiscal 2014.
- Imunon, Inc. stock issued during period, value, treasury stock reissued for fiscal 2014 was $64.48K, a 34.23% decline from fiscal 2013.
- Imunon, Inc. stock issued during period, value, treasury stock reissued for fiscal 2013 was $98.05K, a 8.41% decline from fiscal 2012.
| Period end | Stock Issued During Period, Value, Treasury Stock Reissued 3 month | Stock Issued During Period, Value, Treasury Stock Reissued 12 month |
|---|---|---|
| 2016-12-31 | $101.49K 10-K · filed 2018-03-27 | |
| 2015-12-31 | $86.73K 10-K · filed 2017-03-24 | |
| 2014-12-31 | $64.48K 10-K · filed 2016-03-30 | |
| 2013-12-31 | $98.05K 10-K · filed 2016-03-30 | |
| 2012-12-31 | $107.05K 10-K · filed 2015-03-12 | |
| 2012-03-31 | $50.38K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $15.72K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $131.91K 10-K · filed 2014-03-13 |
| 2011-03-31 | $13.71K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |